{
    "2019-06-25": [
        [
            {
                "time": "2019-06-25",
                "original_text": "Abbvie Decides to Acquire Allergan",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "Acquire",
                        "Allergan"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-14",
                "original_text": "Double Top Spells Trouble for 3 Health Care Stocks",
                "features": {
                    "keywords": [
                        "Double Top",
                        "Trouble",
                        "Health Care Stocks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Buy",
                        "Botox-Maker",
                        "Allergan",
                        "G-20"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2016-12-31",
                "original_text": "Most Important Mergers and Acquisitions of 2016",
                "features": {
                    "keywords": [
                        "Mergers",
                        "Acquisitions",
                        "2016"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Allergan Is a $63 Billion Botox Job for AbbVie",
                "features": {
                    "keywords": [
                        "Allergan",
                        "$63 Billion",
                        "Botox",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-05-10",
                "original_text": "Smith & Nephew directors discussed US listing to boost CEO pay",
                "features": {
                    "keywords": [
                        "Smith & Nephew",
                        "US listing",
                        "CEO pay"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}